Market Scenario:
Polycystic
Ovary Syndrome (PCOS) is a medical condition where the women of reproductive
age suffer from hormonal disorders. This is due to an increase in levels of
male hormones in the body which leads to an irregular menstrual cycle. Women
experience symptoms such as irregular menstrual cycle, increase in facial hair
growth, acne, thinning hair or hair loss on the scalp, weight gain, darkening
of skin and others. Polycystic Ovary Syndrome (PCOS) is caused due to high
levels of androgens, excess insulin, low-grade inflammation, cysts in the
ovaries, and genetic disorders.
The
polycystic ovarian syndrome market is expected to witness tremendous growth
owing to the rising prevalence of polycystic ovarian syndrome. According to the
Centers for Disease Control and Prevention, approximately 5 million women of
reproductive age suffer from the polycystic ovarian syndrome.
Other key
factors such as the growing obesity among women, rising prevalence of diabetes,
increasing hormonal disorders in women, change in sedentary lifestyle,
socioeconomic factors, growing consumption of unhealthy diet, and others are
contributing towards the growth of the market. Diabetes is another risk
factor that leads to the development of the polycystic ovarian syndrome. Such
factors contribute to polycystic ovarian syndrome among women.
However,
factors such as side effects associated with drugs such as weight gain,
cardiovascular risks, increase insulin resistance, abnormal glucose tolerance,
and thromboembolic events are expected to restrict the market growth
during the forecast period.
Segmentation
The
global polycystic ovarian syndrome market is segmented on the basis of
diagnosis, treatment, and end-user. The polycystic ovarian syndrome market, by
diagnosis, is categorized into the pelvic examination, transvaginal ultrasound,
and blood tests. Blood tests are further sub-segmented into hormone levels,
glucose tolerance and cholesterol and triglyceride levels. On the basis of
treatment, the market is segmented into oral contraceptives, antiandrogens,
insulin-sensitizing agents, antidepressant, anti-obesity, and surgery. The
surgery category includes ovarian wedge resection and laparoscopic ovarian
drilling. On the basis of end-user, the market is segmented into hospitals and
clinics, ambulatory surgical centers, diagnostic centers, gynecology centers,
feminist health centers, and others.
On the
basis of region, the global polycystic ovarian syndrome market is segmented
into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The
Americas is sub-segmented into North America and South America. The North
American region is further segmented into the US and Canada. The European
region is divided into two, namely, Western Europe and Eastern Europe. Western
Europe is further classified into Germany, Italy, France, the UK, Spain, and
the rest of Western Europe. The Asia-Pacific region is sub-segmented into
Japan, China, India, Australia, the Republic of Korea, and the rest of
Asia-Pacific. The Middle Eastern and African region is sub-segmented into the
United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the
Middle East and Africa.
Key
players
Some of
the key players in the global polycystic ovarian syndrome market are Bayer AG,
AstraZeneca plc, Abbott, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals,
Inc., Sanofi, Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA,
Bristol-Myer Squibb Company, Neurocrine Biosciences, Inc., Reliance Life
Sciences Pvt. Ltd. Pfizer, Inc., Novartis AG, and Shire Plc.
Regional
Market Summary
The
polycystic ovarian syndrome market is dominated by North America owing to the
rising obesity. According to the Institute for Health Metrics and Evaluation
(IHME), 60% of women were obese or overweight in 2013. Other factors such as
increasing healthcare expenditure, increasing technological advancements, and
adoption of minimally invasive surgeries drive the market growth in this
region.
It is
estimated that Europe was the second largest in the global polycystic ovarian
syndrome market owing to the increasing prevalence of diabetes, obesity, and
increasing research activities in the health industry in this region. According
to the German Federal Ministry of Health in 2014 and 2015, 7.0% of women of age
18 and more suffered from diabetes in Germany. Thus, the increasing prevalence
of diabetes in this region influences the growth of this market in this region.
Asia-Pacific
was projected to be the fastest growing region for the global polycystic
ovarian syndrome market in 2017. The market is expected to witness growth owing
to the rising prevalence of diabetes in women, changing lifestyle, and growing
obesity within the female population. This provides favorable backgrounds for
the market to grow.
The
Middle East and Africa holds the least share in the global polycystic ovarian
syndrome market due to the presence of stringent government policies and poor
economies. However, the market is expected to witness growth due to the rising
healthcare expenditure, growing private sector in the healthcare domain, and insurance
coverage in the Middle East.
Browse
Complete 100 Pages Premium Research Report Enabled with Respective Tables and
Figures @ https://www.marketresearchfuture.com/reports/polycystic-ovarian-syndrome-market-6295
Table of Content
1.
Report Prologue
2.
Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3.
Research Methodology
3.1 Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
4.
Market Dynamics
4.1
Drivers
4.2
Restraints
4.3
Opportunities
4.4
Challenges
4.5
Macroeconomic Indicators
4.6
Technology Trends & Assessment
…Continued!
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment